177 related articles for article (PubMed ID: 12704632)
21. Familial effects of BRCA1 genetic mutation testing: changes in perceived family functioning.
Stroup AM; Smith KR
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):135-41. PubMed ID: 17220342
[TBL] [Abstract][Full Text] [Related]
22. Communicating genetic information in families--a review of guidelines and position papers.
Forrest LE; Delatycki MB; Skene L; Aitken M
Eur J Hum Genet; 2007 Jun; 15(6):612-8. PubMed ID: 17392704
[TBL] [Abstract][Full Text] [Related]
23. Genetic counseling of hemophilia carriers.
Ljung R; Tedgård U
Semin Thromb Hemost; 2003 Feb; 29(1):31-6. PubMed ID: 12640562
[TBL] [Abstract][Full Text] [Related]
24. Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients.
Sorenson JR; Cheuvront B; DeVellis B; Callanan N; Silverman L; Koch G; Sharp T; Fernald G
Am J Med Genet; 1997 May; 70(2):121-9. PubMed ID: 9128929
[TBL] [Abstract][Full Text] [Related]
25. Health first, genetics second: exploring families' experiences of communicating genetic information.
Forrest LE; Curnow L; Delatycki MB; Skene L; Aitken M
Eur J Hum Genet; 2008 Nov; 16(11):1329-35. PubMed ID: 18493266
[TBL] [Abstract][Full Text] [Related]
26. Transmitting balanced translocation carrier information within families: a follow-up study.
Suslak L; Price DM; Desposito F
Am J Med Genet; 1985 Feb; 20(2):227-32. PubMed ID: 3976717
[TBL] [Abstract][Full Text] [Related]
27. Intention to communicate BRCA1/BRCA2 genetic test results to the family.
Barsevick AM; Montgomery SV; Ruth K; Ross EA; Egleston BL; Bingler R; Malick J; Miller SM; Cescon TP; Daly MB
J Fam Psychol; 2008 Apr; 22(2):303-12. PubMed ID: 18410217
[TBL] [Abstract][Full Text] [Related]
28. Gender differences in psychosocial reactions to cystic fibrosis carrier testing.
Newman JE; Sorenson JR; DeVellis BM; Cheuvront B
Am J Med Genet; 2002 Nov; 113(2):151-7. PubMed ID: 12407705
[TBL] [Abstract][Full Text] [Related]
29. Carrier detection and prenatal diagnosis of hemophilia in developing countries.
Peyvandi F
Semin Thromb Hemost; 2005 Nov; 31(5):544-54. PubMed ID: 16276463
[TBL] [Abstract][Full Text] [Related]
30. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.
Bailey DB; Skinner D; Davis AM; Whitmarsh I; Powell C
Pediatrics; 2008 Mar; 121(3):e693-704. PubMed ID: 18310190
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism distribution of Int13, Int22, and St14 VNTRs in a Mexican population and their application in carrier diagnosis of hemophilia A.
Gallegos RM; Aranda HB; Navarrete CP; Espinoza R; Gómez FS; Aranda DA
Am J Hematol; 2004 Sep; 77(1):1-6. PubMed ID: 15307098
[TBL] [Abstract][Full Text] [Related]
32. Family members' perceptions of genetic testing for malignant melanoma--a prospective interview study.
Bergenmar M; Hansson J; Brandberg Y
Eur J Oncol Nurs; 2009 Apr; 13(2):74-80. PubMed ID: 19179113
[TBL] [Abstract][Full Text] [Related]
33. The phases of disclosing BRCA1/2 genetic information to offspring.
Clarke S; Butler K; Esplen MJ
Psychooncology; 2008 Aug; 17(8):797-803. PubMed ID: 18646247
[TBL] [Abstract][Full Text] [Related]
34. Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives.
Cypowyj C; Eisinger F; Huiart L; Sobol H; Morin M; Julian-Reynier C
Psychooncology; 2009 Feb; 18(2):209-15. PubMed ID: 19061202
[TBL] [Abstract][Full Text] [Related]
35. Psychosocial aspects of genetic testing.
Cameron LD; Muller C
Curr Opin Psychiatry; 2009 Mar; 22(2):218-23. PubMed ID: 19553879
[TBL] [Abstract][Full Text] [Related]
36. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
[TBL] [Abstract][Full Text] [Related]
37. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
38. Fertility intentions following testing for a BRCA1 gene mutation.
Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
[TBL] [Abstract][Full Text] [Related]
39. Genetic studies in variegate porphyria in Spain. Identification of gene mutations and family study for carrier detection.
Lecha M; Badenas C; Puig S; Orfila J; Milà M; To-Figueras J; Muñoz C; Mercader P; Herrero C
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):974-9. PubMed ID: 16922948
[TBL] [Abstract][Full Text] [Related]
40. Family communication regarding inherited high cholesterol: why and how do patients disclose genetic risk?
van den Nieuwenhoff HW; Mesters I; Gielen C; de Vries NK
Soc Sci Med; 2007 Sep; 65(5):1025-37. PubMed ID: 17507128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
